Fig. 7 | Scientific Reports

Fig. 7

From: TMEM101 expression and its impact on immune cell infiltration and prognosis in hepatocellular carcinoma

Fig. 7

TMEM101 was compared with other published biomarkers for its diagnostic effectiveness. (A–D) The expression levels of AFP (A), EFNA3 (B), MDK (C), and SMYD5 (D) in HCC and normal liver tissues. (E–H) The ROC curve demonstrated the diagnostic value of AFP (E), EFNA3 (F), MDK (G), and SMYD5 (H) in HCC patients. (I–K) The time-dependent ROC curves of the AFP, EFNA3, MDK, and SMYD5 were compared for 1-, 3-, and 5-year OS in HCC, respectively.

Back to article page